Revisiting the persistent negative symptoms proxy score using the Clinical Assessment Interview for Negative Symptoms

被引:8
作者
Li, Ying [1 ,2 ,3 ,6 ]
Li, Wen-xiu [3 ]
Zou, Ying-min [1 ,2 ,6 ]
Yang, Zhuo-ya [1 ,2 ,6 ]
Xie, Dong-jie [1 ,2 ,6 ]
Yang, Yin [1 ,6 ]
Lu, Simon S. Y. [1 ,4 ,6 ]
Strauss, Gregory P. [5 ]
Cheung, Eric F. C. [4 ]
Chan, Raymond C. K. [1 ,2 ,6 ]
机构
[1] Inst Psychol, Neuropsychot & Appl Cognit Neurosci Lab, CAS Key Lab Mental Hlth, Beijing, Peoples R China
[2] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China
[3] Haidian Dist Mental Hlth Prevent Treatment Hosp, Beijing, Peoples R China
[4] Castle Peak Hosp, Hong Kong, Hong Kong, Peoples R China
[5] Univ Georgia, Dept Psychol, Athens, GA 30602 USA
[6] Chinese Acad Sci, Inst Psychol, 16 Lincui Rd, Beijing 100101, Peoples R China
关键词
CAINS; Persistent negative symptoms; Schizophrenia; ROC curve; 1ST EPISODE SCHIZOPHRENIA; SCALE; VALIDATION; VERSION; DEPRESSION; APATHY;
D O I
10.1016/j.schres.2018.07.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The present study aimed to validate a severity cut-off of negative symptoms for persistent negative symptoms (PNS) identification using the Clinical Assessment Interview for Negative Symptoms (CAINS). Method: A total of 206 patients with schizophrenia were recruited and divided into the PNS group (n = 57) and the Non-PNS group (n = 149) using PNS criteria based on the SANS and the SAPS. To determine the appropriate cut-offs on the CAINS in identifying PNS, Receiver Operating Characteristic (ROC) curve analysis was conducted in the PNS and Non-PNS groups. Results: Our results showed that the cutoffs for identifying PNS on the CAINS total score, the Motivation and Pleasure (MAP) subscale score and the Expression (EXP) subscale score were 25, 17, and 5 respectively. Area Under the Curve (AUC) analysis indicated excellent discrimination of the PNS group from the Non-PNS group using the cut-off for the CAINS total score. However, discrimination was somewhat better for the MAP subscale score than the EXP subscale score. The Positive Predictive Value (PPV) and Negative Predictive Value (NPV) of the MAP subscale were 81.54% and 97.16%. Conclusion: We found that the cut-off scores derived from the CAINS to identify PNS are comparable to existing scales. The CAINS offers an alternative means in identifying PNS patients in clinical trials that overcomes methodological and conceptual limitations of older scales. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:248 / 253
页数:6
相关论文
共 43 条
  • [1] ASSESSING DEPRESSION IN SCHIZOPHRENIA - THE CALGARY DEPRESSION SCALE
    ADDINGTON, D
    ADDINGTON, J
    MATICKATYNDALE, E
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 : 39 - 44
  • [2] ALBECK M J, 1990, Ugeskrift for Laeger, V152, P1650
  • [3] CORRELATIONAL STUDIES OF THE SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS AND THE SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOMS - AN OVERVIEW AND UPDATE
    ANDREASEN, NC
    ARNDT, S
    MILLER, D
    FLAUM, M
    NOPOULOS, P
    [J]. PSYCHOPATHOLOGY, 1995, 28 (01) : 7 - 17
  • [4] ANDREASEN NC, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P49
  • [5] Andreasen NC, 1984, Psychiatrie & Psychobiologie, DOI [10.1037/t48377-000, DOI 10.1037/T48377-000]
  • [6] The CAINS: Theoretical and Practical Advances in the Assessment of Negative Symptoms in Schizophrenia
    Barch, Deanna M.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (02) : 133 - 135
  • [7] Clinimetric Evaluation of the Simpson-Angus Scale in Older Adults With Schizophrenia
    Blanchet, Pierre J.
    Rompre, Pierre H.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (01) : 36 - 39
  • [8] Does considering duration of negative symptoms increase their specificity for schizophrenia?
    Bottlender, R
    Sato, T
    Jäger, M
    Kunze, I
    Groll, C
    Borski, I
    Möller, HJ
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (2-3) : 321 - 322
  • [9] Persistent negative symptoms in schizophrenia: An overview
    Buchanan, Robert W.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (04) : 1013 - 1022
  • [10] Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia
    Buchanan, Robert W.
    Panagides, John
    Zhao, Jun
    Phiri, Phillip
    den Hollander, Wil
    Ha, Xianwei
    Kouassi, Alex
    Alphs, Larry
    Schooler, Nina
    Szegedi, Armin
    Cazorla, Pilar
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (01) : 36 - 45